Pembrolizumab is a medication used in the management and treatment of various oncologic conditions. It is in the cancer immunotherapy class of drugs. This activity will highlight pembrolizumab's mechanism of action, indications, adverse event profile, and other key factors (e.g., non-approved indications currently in clinical trials, administration, dosing, monitoring, and relevant interactions) pertinent for members of the interprofessional team in the management of patients with advanced cancers.

**Objectives:**
- Identify the indications for pembrolizumab.
- Summarize the mechanism of action pembrolizumab.
- Explain the importance of monitoring for patients on pembrolizumab, including immune-mediated adverse events.
- Outline the importance of collaboration and coordination among the interprofessional team when dosing and monitoring pembrolizumab immunotherapy to improve patient outcomes with advanced cancers.